Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial oxidative phosphorylation (OXPHOS) system comprises five multi-subunit enzyme complexes (Complexes I–V) embedded in the inner mitochondrial membrane, along with two mobile electron carriers. This system is central to cellular energy production, generating ATP via electron transport and chemiosmosis. Defects in any component can lead to severe metabolic diseases. Many drugs and poisons target these enzymes directly. Reactive oxygen species produced as side products contribute both physiologically—as signaling molecules—and pathologically—to aging/disease processes if not properly controlled.
Inhibition of electron transport, uncoupling of oxidative phosphorylation, or direct inhibition of ATP synthase.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Oxidative Phosphorylation System (OXPHOS).